Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPEx: Palbociclib + Endocrine Therapy in High Risk Early Breast Cancer
NCT04247633Phase 2Unknown
- Sponsor
- Samsung Medical Center
- Start
- Feb 2020
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in breast cancer, sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04247633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04247633.